Effects of mouthrinses with chlorhexidine and zinc ions combined with fluoride on the viability and glycolytic activity of dental plaque.
Inhibition of plaque acidogenicity by a mouthrinse with chlorhexidine (CHX) or zinc ions has been ascribed to a prolonged bacteriostasis due to substantive properties of the agents. The present aim was to study the effects of mouthrinses with CHX and Zn ions combined with fluoride on the viability and glycolytic activity of dental plaque in order to assess the bacteriostatic versus possible bactericidal effects. Following 2 d of plaque accumulation, 4 groups of 10 students rinsed with either 12 mM NaF (F), 0.55 mM CHX diacetate+F (F-CHX), 10 mM Zn acetate+F (F-Zn), or with the three agents in combination (F-CHX-Zn). Plaque samples were collected before and 90 min after mouthrinsing. Thereafter, the in vivo plaque pH response to sucrose was monitored in each student using touch microelectrodes. F-CHX and F-CHX-Zn reduced the in vivo pH fall significantly as compared with F, whereas F-Zn exerted a non-significant inhibition. Pooled pre- and post-rinse plaque samples were used to measure the pH fall during fermentation of [14C]-glucose, and the glycolytic profiles were analyzed by HPLC. Bacterial viability was assessed by counting the colony-forming units (CFU). All mouthrinses except F reduced glucose consumption and acid formation and thus the pH fall. F-CHX reduced the CFU equal to the reduction of glucose consumption, indicating that inhibition of plaque acidogenicity was due to a bactericidal rather than a bacteriostatic effect. F and F-Zn did not reduce the CFU, thus F-Zn decreased glucose metabolism without affecting plaque viability. F-CHX-Zn reduced both the CFU and glucose metabolism of surviving plaque microorganisms.
Giertsen
E
E
Department of Cariology and Endodontics, Faculty of Dentistry, University of Bergen, Norway.
Scheie
A A
AA
D000328:Adult; D000704:Analysis of Variance; D000891:Anti-Infective Agents, Local / Q000494:pharmacology; D001421:Bacteria, Anaerobic / Q000187:drug effects* / Q000378:metabolism; D002710:Chlorhexidine / Q000494:pharmacology; D015169:Colony Count, Microbial; D003773:Dental Plaque / Q000188:drug therapy / Q000378:metabolism* / Q000382:microbiology; D004311:Double-Blind Method; D004338:Drug Combinations; D005260:Female; D006019:Glycolysis / Q000187:drug effects*; D006801:Humans; D006863:Hydrogen-Ion Concentration / Q000187:drug effects; D007477:Ions; D008297:Male; D009067:Mouthwashes / Q000494:pharmacology* / Q000627:therapeutic use; D012969:Sodium Fluoride / Q000494:pharmacology; D015032:Zinc / Q000494:pharmacology
D000891:Anti-Infective Agents, Local; D004338:Drug Combinations; D007477:Ions; D009067:Mouthwashes; D012969:Sodium Fluoride; D015032:Zinc; D002710:Chlorhexidine